Literature DB >> 16441236

Transcreener: screening enzymes involved in covalent regulation.

Robert G Lowery1, Karen Kleman-Leyer.   

Abstract

Enzymes that catalyse group transfer reactions comprise a significant fraction of the human proteome and are a rich source of drug targets because of their role in covalent regulatory cycles. Phosphorylation, glycosylation, sulfonation, methylation and acetylation represent some of the key types of group transfer reactions that modulate the function of diverse biomolecules through covalent modification. Development of high-throughput screening methods for these enzymes has been problematic because of the diversity of acceptor substrates. Recently, the authors developed a novel assay platform called Transcreener that relies upon fluorescence detection of the invariant reaction product of a group transfer reaction, usually a nucleotide. This platform enables screening of any isoform in a family of group transfer enzymes, with any acceptor substrate, using the same assay reagents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441236     DOI: 10.1517/14728222.10.1.179

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  12 in total

1.  Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay.

Authors:  Tony A Klink; Matt Staeben; Kim Twesten; Andrew L Kopp; Meera Kumar; Rebecca Schall Dunn; Cori A Pinchard; Karen M Kleman-Leyer; Martin Klumpp; Robert G Lowery
Journal:  J Biomol Screen       Date:  2011-09-28

2.  A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.

Authors:  Douglas S Auld; Ya-Qin Zhang; Noel T Southall; Ganesha Rai; Marc Landsman; Jennifer MacLure; Daniel Langevin; Craig J Thomas; Christopher P Austin; James Inglese
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

3.  Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Authors:  Karen M Kleman-Leyer; Tony A Klink; Andrew L Kopp; Thane A Westermeyer; Mark D Koeff; Brad R Larson; Tracy J Worzella; Cori A Pinchard; Sebastianus A T van de Kar; Guido J R Zaman; Jorrit J Hornberg; Robert G Lowery
Journal:  Assay Drug Dev Technol       Date:  2009-02       Impact factor: 1.738

4.  Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.

Authors:  Matt Staeben; Karen M Kleman-Leyer; Andrew L Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  Assay Drug Dev Technol       Date:  2010-06       Impact factor: 1.738

5.  Fluorescence polarization assays in small molecule screening.

Authors:  Wendy A Lea; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

6.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

7.  A fluorescent, reagentless biosensor for ADP based on tetramethylrhodamine-labeled ParM.

Authors:  Simone Kunzelmann; Martin R Webb
Journal:  ACS Chem Biol       Date:  2010-04-16       Impact factor: 5.100

8.  Development and validation of a high-density fluorescence polarization-based assay for the trypanosoma RNA triphosphatase TbCet1.

Authors:  Christophe Antczak; David Shum; Constantin Radu; Venkatraman E Seshan; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2009-03       Impact factor: 1.339

9.  Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity.

Authors:  Thomas Zielinski; Adam J Kimple; Stephanie Q Hutsell; Mark D Koeff; David P Siderovski; Robert G Lowery
Journal:  J Biomol Screen       Date:  2009-12

10.  A biosensor for fluorescent determination of ADP with high time resolution.

Authors:  Simone Kunzelmann; Martin R Webb
Journal:  J Biol Chem       Date:  2009-09-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.